Toxocara canis in Dogs: Lifecycle, Visceral Larva Migrans Zoonosis, and Anthelmintic Treatment

Introduction

Toxocara canis is a globally distributed ascarid nematode that parasitizes the small intestine of canids, particularly domestic dogs. This parasite represents one of the most prevalent gastrointestinal helminths in canine populations worldwide and carries significant zoonotic potential through the syndromes of visceral larva migrans (VLM) and ocular larva migrans (OLM) [1, 2, 38]. The parasite's biological success is attributable to its complex lifecycle, which includes transplacental and transmammary transmission routes that ensure high infection rates in neonatal puppies [2, 38]. Understanding the biophysical mechanisms of larval migration, host immune modulation, and anthelmintic pharmacology is essential for veterinary practitioners managing canine patients and implementing public health control strategies.

Morphology and Taxonomy

Toxocara canis belongs to the phylum Nematoda, order Ascaridida, and family Toxocaridae. Adult worms are robust, cream-colored nematodes with a characteristic arrow-shaped anterior end bearing three prominent lips. Adult males measure 4 to 6 cm in length, while females reach 6 to 15 cm. The posterior end of males possesses a copulatory bursa with spicules. Eggs are subglobose, measuring 75 to 90 micrometers in diameter, with a thick, pitted outer shell and a dark brown, single-celled embryo when freshly shed. The distinctive pitted shell surface is a key diagnostic feature differentiating T. canis eggs from those of Toxocara cati, which have a smoother shell surface [3].

Molecular characterization has confirmed genetic variation among Toxocara isolates from different hosts. Ribosomal DNA sequencing of the internal transcribed spacer (ITS) regions has demonstrated that T. canis from dogs and T. cati from cats represent distinct genetic lineages, though a variant from cats in Kuala Lumpur, Malaysia showed intermediate molecular characteristics [3].

Lifecycle

The lifecycle of T. canis is among the most complex of any canine nematode, involving multiple transmission routes and the capacity for larval hypobiosis (arrested development) in somatic tissues.

Direct Lifecycle (Adult Dogs)

Adult dogs acquire infection through ingestion of embryonated eggs from contaminated environments. Following ingestion, eggs hatch in the small intestine, releasing second-stage larvae (L2). These larvae penetrate the intestinal wall and enter the portal circulation, migrating to the liver within 24 to 48 hours. From the liver, larvae travel via the hepatic veins to the right heart and then to the pulmonary circulation. In the lungs, larvae break through alveolar capillaries into the alveoli, molt to third-stage larvae (L3), and migrate up the tracheobronchial tree. They are then coughed up, swallowed, and return to the small intestine, where they molt to fourth-stage larvae (L4) and finally to adult worms. The prepatent period for this tracheal migration route is approximately 4 to 5 weeks.

Transplacental Transmission

Transplacental transmission is the most epidemiologically significant route of infection in puppies. In pregnant bitches, reactivation of hypobiotic larvae (L3) from somatic tissues occurs under the influence of hormonal changes during late gestation. These larvae migrate across the placenta during the last trimester, infecting fetuses in utero. Larvae reach the fetal liver and lungs, and after birth, complete the tracheal migration to the small intestine. This route results in patent infections in puppies as early as 2 to 3 weeks of age, with adult worms producing eggs by 4 to 5 weeks postpartum.

Transmammary Transmission

Transmammary transmission occurs when puppies ingest L3 larvae present in the colostrum and milk of lactating bitches. This route is less quantitatively significant than transplacental transmission but contributes to early postnatal infection. Larvae transmitted via milk bypass the hepatic-pulmonary migration and develop directly in the small intestine, resulting in a shorter prepatent period.

Paratenic Hosts

Toxocara canis larvae can infect a wide range of paratenic hosts, including rodents, birds, earthworms, and cockroaches [40]. When dogs ingest infected paratenic hosts, larvae are released in the digestive tract and complete development to adult worms without undergoing tracheal migration. This route is particularly important for adult dogs that hunt or scavenge.

Egg Development and Environmental Contamination

Adult female T. canis produce prodigious numbers of eggs, with estimates of 20,000 to 200,000 eggs per worm per day. Unembryonated eggs are shed in feces and require a period of development in the environment to become infective. Under optimal conditions (temperatures of 25 to 30 degrees Celsius, high humidity, and shade), eggs embryonate to the L2 stage within 2 to 4 weeks. Embryonated eggs are extremely resistant to environmental degradation and can remain viable in soil for years [38, 43].

graph TD
    A[Adult worms in small intestine of dog], > B[Eggs shed in feces]
    B, > C[Unembryonated eggs in environment]
    C, > D[Embryonation to L2 in soil 2-4 weeks]
    D, > E[Ingestion by dog]
    D, > F[Ingestion by paratenic host]
    F, > G[Paratenic host ingested by dog]
    E, > H[Larvae penetrate intestinal wall]
    H, > I[Hepatic portal circulation to liver]
    I, > J[Right heart to pulmonary circulation]
    J, > K[Larvae in alveoli, molt to L3]
    K, > L[Tracheal migration, coughed up and swallowed]
    L, > A
    G, > M[Larvae released in dog intestine]
    M, > A
    subgraph Pregnant Bitch
        N[Reactivation of hypobiotic larvae], > O[Transplacental transmission to fetus]
        O, > P[Larvae in fetal liver and lungs]
        P, > Q[After birth, tracheal migration to intestine]
        Q, > A
    end
    subgraph Lactating Bitch
        R[Larvae in mammary tissue], > S[Transmammary transmission via milk]
        S, > T[Direct development in puppy intestine]
        T, > A
    end

Epidemiology

Toxocara canis has a cosmopolitan distribution, with prevalence rates varying by geographic region, dog population (owned versus stray), age, and management practices. Prevalence in dogs ranges from 5% to over 80% in different studies [4, 1, 5, 6, 2, 7, 8, 42].

Prevalence in Different Populations

A survey of well-cared-for dogs in Jamaica found a T. canis prevalence of 12.5% [1]. In contrast, studies of working sheepdogs on the North Island of New Zealand reported a prevalence of 21.4% [4]. High prevalence rates have been documented in stray dog populations in Iran (30.8%) [42] and in dogs from Saipan, Northern Mariana Islands (38.5%) [5]. A coprological assessment of domestic carnivores in public areas in São Paulo State, Brazil found T. canis eggs in 14.2% of samples [6]. Studies in rural areas of the Mekong River basin reported prevalence rates of 15.6% [8].

Age-Related Patterns

Age is the most significant risk factor for T. canis infection. Puppies under 6 months of age consistently show the highest prevalence and intensity of infection due to transplacental and transmammary transmission. Adult dogs typically have lower infection rates and worm burdens, likely due to age-acquired immunity that limits larval reactivation and establishment of patent infections.

Environmental Contamination

Contamination of public parks, playgrounds, and soil with T. canis eggs represents a significant public health risk. Studies in Brazil found Toxocara spp. eggs in 23.5% of soil samples from public parks and squares [43]. Similar contamination rates have been reported globally, with eggs persisting in soil for extended periods due to their robust shell structure.

Clinical Signs in Dogs

Puppies

Puppies with heavy T. canis burdens present with a characteristic syndrome including a pot-bellied appearance, poor growth, dull hair coat, diarrhea, vomiting, and occasionally intestinal obstruction. Large numbers of adult worms can cause intussusception or intestinal rupture. Respiratory signs, including coughing and pneumonia, may occur during the pulmonary migration phase. Heavy infections can be fatal in young puppies.

Adult Dogs

Adult dogs with patent T. canis infections are often asymptomatic, particularly when worm burdens are low. However, heavy infections can cause vomiting, diarrhea, weight loss, and poor coat condition. Chronic infection may contribute to subclinical nutritional deficiencies.

Pathogenesis

The pathogenesis of T. canis infection involves both mechanical damage from larval migration and adult worm feeding, as well as immunopathological responses.

Larval Migration

During hepatic migration, larvae cause focal necrosis and hemorrhage, with subsequent granulomatous inflammation. In the lungs, larval penetration of alveolar walls causes hemorrhage, edema, and eosinophilic infiltration. The severity of pulmonary pathology correlates with larval burden.

Adult Worm Effects

Adult worms in the small intestine compete with the host for nutrients, particularly proteins and vitamins. Heavy burdens can cause mechanical obstruction of the intestinal lumen. The worms' feeding activity, which involves ingesting intestinal contents and occasionally blood, can contribute to anemia in severe cases.

Immune Modulation

Toxocara canis larvae secrete immunomodulatory molecules that suppress host Th1 responses and promote Th2 polarization. This immune modulation facilitates larval survival and may influence the host's response to concurrent infections or vaccinations.

Diagnosis

Fecal Flotation

Fecal flotation using centrifugal or passive methods with saturated salt or sugar solutions (specific gravity 1.20 to 1.25) is the standard diagnostic technique for detecting T. canis eggs. The characteristic pitted shell and subglobose shape allow differentiation from other nematode eggs. Sensitivity is highest when using centrifugal flotation with a coverslip.

Molecular Diagnostics

PCR-based assays targeting the ITS-1 and ITS-2 regions of ribosomal DNA provide species-specific identification of T. canis eggs and larvae [3, 9]. Real-time PCR assays offer higher sensitivity than conventional microscopy, particularly for detecting low-intensity infections. Molecular methods are also valuable for differentiating T. canis from T. cati in mixed infections.

Serology

Serological detection of anti-Toxocara antibodies using enzyme-linked immunosorbent assays (ELISAs) is primarily used for human diagnosis but has limited application in canine clinical practice. Seropositivity in dogs indicates exposure but does not distinguish between current patent infection and past exposure.

Anthelmintic Treatment

Drug Classes and Mechanisms

Several anthelmintic drug classes are effective against T. canis, with varying efficacy against different lifecycle stages.

Pyrantel Pamoate

Pyrantel pamoate is a nicotinic acetylcholine receptor agonist that causes spastic paralysis of adult worms, leading to their expulsion from the intestine. It is effective against adult and L4 stages but has limited activity against migrating larvae. The standard dose is 5 mg/kg orally, with a repeat dose recommended after 2 to 3 weeks.

Fenbendazole

Fenbendazole is a benzimidazole that binds to beta-tubulin, inhibiting microtubule polymerization and disrupting glucose uptake in nematodes. It has efficacy against adult worms, L4 larvae, and migrating larvae. The recommended protocol for puppies is 50 mg/kg orally once daily for 3 consecutive days. For pregnant bitches, fenbendazole administered from day 40 of gestation through day 14 postpartum reduces transplacental and transmammary transmission.

Milbemycin Oxime

Milbemycin oxime is a macrocyclic lactone that potentiates glutamate-gated chloride channels, causing hyperpolarization and paralysis of nematodes. It is effective against adult T. canis and has some activity against migrating larvae. The standard dose is 0.5 mg/kg orally.

Macrocyclic Lactone Resistance Mechanisms

Transcriptional responses to macrocyclic lactone exposure in T. canis larvae have been characterized using RNA-seq analysis [10]. Exposure to macrocyclic lactones induces upregulation of genes encoding P-glycoprotein drug transporters, which function as ATP-dependent efflux pumps that reduce intracellular drug concentrations [10, 11]. The repertoire of P-glycoprotein transporters in T. canis includes multiple isoforms with differential expression patterns across lifecycle stages [11]. These efflux mechanisms represent a potential pathway for the development of anthelmintic resistance, though clinical resistance in T. canis remains less documented than in some livestock nematodes.

Treatment Protocols

Puppies

Puppies should be treated at 2, 4, 6, and 8 weeks of age, followed by monthly treatments until 6 months of age. Pyrantel pamoate is commonly used for initial treatments due to its safety profile in young puppies. Fenbendazole is preferred when broader spectrum activity against migrating larvae is desired.

Adult Dogs

Adult dogs should be treated at least quarterly, with monthly treatment recommended in high-risk environments. Milbemycin oxime administered as part of monthly heartworm prophylaxis provides continuous suppression of T. canis infection.

Pregnant Bitches

Fenbendazole administered daily from day 40 of gestation through day 14 postpartum significantly reduces larval transmission to puppies. This protocol targets reactivated hypobiotic larvae and reduces both transplacental and transmammary transmission.

Zoonotic Significance: Visceral and Ocular Larva Migrans

Visceral Larva Migrans

Visceral larva migrans (VLM) occurs when humans, typically young children, ingest embryonated T. canis eggs from contaminated soil or fomites. In the human paratenic host, larvae hatch in the intestine, penetrate the intestinal wall, and migrate through somatic tissues but cannot complete development to adult worms. Larvae become encapsulated in granulomas in various organs, most commonly the liver, lungs, and central nervous system [12, 13, 35, 45].

Clinical manifestations of VLM include fever, hepatomegaly, pulmonary infiltrates with eosinophilia, and hypergammaglobulinemia. Hepatic lesions appear as hypoechoic or hypodense nodules on ultrasound or computed tomography [12, 13, 35]. Severe cases can involve the myocardium or central nervous system, causing myocarditis or encephalitis [14].

Ocular Larva Migrans

Ocular larva migrans (OLM) results from larval migration into the eye, typically in older children or adults. Larvae cause granulomatous inflammation in the retina, leading to vision loss, strabismus, and leukocoria. OLM can be mistaken for retinoblastoma, necessitating careful diagnostic differentiation [15].

Global Burden

Human toxocariasis is recognized as a neglected parasitic infection with significant global impact [16, 17, 18, 19, 20, 36]. Seroprevalence studies indicate widespread exposure, with rates varying from 2% to 80% depending on geographic region and population demographics [21, 22, 23, 24, 25, 26, 27, 37]. A systematic review and meta-analysis of toxocariasis in Iran reported a pooled seroprevalence of 12.5% in the general population [26]. Studies in North Africa have documented seroprevalence rates ranging from 5% to 45% [24]. In China, seroprevalence varies from 3% to 35% across different provinces [25]. The global burden of human toxocariasis has been estimated to affect over 1 billion people, with the highest prevalence in tropical and subtropical regions [16, 38].

Risk Factors

Risk factors for human toxocariasis include geophagia (pica), contact with dogs, living in rural areas, low socioeconomic status, and poor hygiene practices [21, 28, 29, 7, 30, 33, 41, 42]. Children aged 2 to 7 years are at highest risk due to hand-to-mouth behavior and increased environmental exposure. Occupational exposure in veterinarians, kennel workers, and farmers also increases risk [21].

Diagnosis in Humans

Human toxocariasis is diagnosed primarily through serological testing using ELISA with Toxocara excretory-secretory (TES) antigens [39]. Western blot confirmation is recommended for borderline or equivocal results. Eosinophilia and elevated total IgE are supportive laboratory findings. Imaging studies, including ultrasound, CT, and MRI, can identify granulomatous lesions in affected organs [12, 13, 35].

Zoonotic Prevention

Prevention of human toxocariasis requires a multifaceted approach targeting both canine and environmental sources of infection.

Canine Management

Regular deworming of dogs, particularly puppies and pregnant bitches, is the cornerstone of prevention. Monthly administration of anthelmintics with activity against T. canis, such as milbemycin oxime, provides continuous suppression of egg shedding. Prompt removal and proper disposal of canine feces from public areas, playgrounds, and parks reduces environmental contamination.

Environmental Control

Public education campaigns should emphasize the importance of hand washing after contact with dogs or soil, covering sandboxes when not in use, and preventing dogs from defecating in children's play areas. Health education focused on larva migrans has been shown to improve knowledge and reduce risk behaviors in endemic areas [6].

Public Health Surveillance

Surveillance of human toxocariasis through seroprevalence studies and case reporting provides data for targeted intervention programs [16, 17, 18, 19, 20, 36]. Integration of veterinary and public health surveillance systems supports a One Health approach to toxocariasis control.

Conclusion

Toxocara canis remains a significant canine parasite with substantial zoonotic implications. The parasite's complex lifecycle, including transplacental and transmammary transmission, ensures high infection rates in puppies and persistent environmental contamination. Effective control requires regular anthelmintic treatment of dogs, environmental management, and public education. Understanding the molecular mechanisms of anthelmintic action and potential resistance pathways, including P-glycoprotein-mediated drug efflux, is essential for maintaining the efficacy of current treatment protocols. Continued research into larval biology, host immune responses, and drug resistance mechanisms will inform future control strategies for this globally important zoonotic nematode.

References

[1] Robinson RD, Thompson DL, Lindo JF. A survey of intestinal helminths of well-cared-for dogs in Jamaica, and their potential public health significance. J Helminthol. 1989. URL: https://pubmed.ncbi.nlm.nih.gov/2723384/

[2] Jenkins DJ. Toxocara canis in Australia. Adv Parasitol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32381231/

[3] Zhu XQ, Jacobs DE, Chilton NB, et al. Molecular characterization of a Toxocara variant from cats in Kuala Lumpur, Malaysia. Parasitology. 1998. URL: https://pubmed.ncbi.nlm.nih.gov/9778638/

[4] O'Connell A, Scott I, Cogger N, et al. Parasitic Nematode and Protozoa Status of Working Sheepdogs on the North Island of New Zealand. Animals (Basel). 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30889826/

[5] Kelly MA, Anderson K, Castro PDJ, et al. High prevalence of gastrointestinal parasites in dogs from Saipan, Northern Mariana Islands, including the zoonotic Ancylostoma ceylanicum. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41606661/

[6] Silva AID, Moura ALA, Galetti BM, et al. Coprological assessment of domestic carnivores in public areas and health education focused on larva migrans in São Paulo State, Brazil. Rev Bras Parasitol Vet. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41370554/

[7] Kohansal MH, Fazaeli A, Nourian A, et al. Dogs' Gastrointestinal Parasites and their Association with Public Health in Iran. J Vet Res. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/29978072/

[8] Otake Sato M, Sato M, Yoonuan T, et al. The role of domestic dogs in the transmission of zoonotic helminthes in a rural area of Mekong river basin. Acta Parasitol. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28426425/

[9] Torkan S, Ghandehari-Alavijeh MR, Khamesipour F. Survey of the prevalence of Toxocara cati in stray cats in Isfahan city, Iran by PCR method. Trop Biomed. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/33592923/

[10] Quintana TA, Brewer MT, Chelladurai JRJ. Transcriptional responses to in vitro macrocyclic lactone exposure in Toxocara canis larvae using RNA-seq. bioRxiv. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39763735/

[11] Jesudoss Chelladurai JRJ, Martin KA, Vardaxis P, et al. Repertoire of P-glycoprotein drug transporters in the zoonotic nematode Toxocara canis. Sci Rep. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36973306/

[12] Osama MA, Dhawan S, Ranjan P, et al. Liver abscesses caused by visceral larva migrans: Aimless wanderer separated from the host. Trop Doct. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/35912514/

[13] Arighi P, Hausbauer GE, Vázquez MG, et al. [Visceral larva migrans syndrome and hepatic abscess: A case report]. Arch Argent Pediatr. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/30457730/

[14] Zibaei M. Helminth Infections and Cardiovascular Diseases: Toxocara Species is Contributing to the Disease. Curr Cardiol Rev. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/27492228/

[15] Iddawela D, Ehambaram K, Bandara P. Prevalence of Toxocara antibodies among patients clinically suspected to have ocular toxocariasis: A retrospective descriptive study in Sri Lanka. BMC Ophthalmol. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28438141/

[16] Antonopoulos A, Giannelli A, Morgan ER, et al. Quantifying the neglected: Initial estimation of the global burden and economic impact of human toxocariasis. Curr Res Parasitol Vector Borne Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38872976/

[17] Henke K, Ntovas S, Xourgia E, et al. Who Let the Dogs Out? Unmasking the Neglected: A Semi-Systematic Review on the Enduring Impact of Toxocariasis, a Prevalent Zoonotic Infection. Int J Environ Res Public Health. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37947530/

[18] Carlin EP, Tyungu DL. Toxocara: Protecting pets and improving the lives of people. Adv Parasitol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32381204/

[19] Rostami A, Ma G, Wang T, et al. Human toxocariasis - A look at a neglected disease through an epidemiological 'prism'. Infect Genet Evol. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31412276/

[20] Chen J, Liu Q, Liu GH, et al. Toxocariasis: a silent threat with a progressive public health impact. Infect Dis Poverty. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29895324/

[21] Said A, Khattak I, Abbas RZ, et al. Toxocara canis seropositivity in different exposure groups in the Khyber Pakhtunkhwa province of Northwest Pakistan. Parasitol Res. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36890297/

[22] Maroufi Y, Faridi A, Khademerfan M, et al. Seroepidemiological Study of Toxocariasis in Children Aged 6-14 Year Old in Sanandaj, Western Iran. Iran J Parasitol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33082809/

[23] Shafiei R, Rahimi MT, Emameh RZ, et al. Status of human toxocariasis, a neglected parasitic zoonosis in Iran: a systematic review from past to current. Trop Doct. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32998656/

[24] Adeel AA. Seroepidemiology of human toxocariasis in North Africa. Adv Parasitol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32381215/

[25] Kong L, Peng HJ. Current epidemic situation of human toxocariasis in China. Adv Parasitol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32381211/

[26] Abbaszadeh Afshar MJ, Zahabiun F, Heydarian P, et al. A Systematic Review and Meta-analysis of Toxocariasis in Iran: Is it Time to Take it Seriously? Acta Parasitol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32319035/

[27] Lötsch F, Vingerling R, Spijker R, et al. Toxocariasis in humans in Africa - A systematic review. Travel Med Infect Dis. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/29037977/

[28] Omer FM, Awadalla NJ, Alsaleem SA, et al. Toxocara Awareness Among Medical Practitioners in Saudi Arabia. Ecohealth. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34014415/

[29] Sharma R, Singh BB, Gill JPS, et al. Canine parasitic zoonoses in India: status and issues. Rev Sci Tech. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/30160698/

[30] Sharma R, Singh BB, Gill JP. Larva migrans in India: veterinary and public health perspectives. J Parasit Dis. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/26688621/

[31] Walcher DL, Cruz LAX, de Lima Telmo P, et al. Lactobacillus rhamnosus reduces parasite load on Toxocara canis experimental infection in mice, but has no effect on the parasite in vitro. Parasitol Res. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29243027/

[32] Ma G, Tan Y, Hu L, et al. Short communication: Experimental toxocarosis in Chinese Kun Ming mice: Dose-dependent larval distribution and modulation of immune responses. Res Vet Sci. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/266797